NIH VideoCast - Extracellular vesicles released by glioblastoma cells: saboteurs, biomarkers and therapeutics

Skip Navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Extracellular vesicles released by glioblastoma cells: saboteurs, biomarkers and therapeutics

Loading... Loading video...

327 Views

Air date:	Wednesday, May 10, 2017, 3:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 327 (82 Live, 245 On-demand)
Category:	WALS - Wednesday Afternoon Lectures
Runtime:	00:56:15
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	NIH Director's Wednesday Afternoon Lecture Series Xandra Breakefield, Ph.D. is a basic scientist with a strong background in molecular genetics and neuroscience. She focuses her research efforts on: gene therapy for neurologic diseases; and elucidation of the role of extracellular vesicles (EVs) released from cancer cells in tumor progression. She led early studies demonstrating mutant RNA in serum EVs from glioblastoma patients as biomarkers. Professor Breakefield has received a number of awards for her work, including a McKnight Foundation Neuroscience Development Award, two Javits Neuroscience Investigator Awards, the Society for Neuroscience Mika Salpeter Lifetime Achievement Award, and the Harvard Medical School William Silen Lifetime Achievement Mentoring Award. She is a member of the National Academy of Arts and Sciences and past president of the American Society of Gene and Cell Therapy. For more information go to https://oir.nih.gov/wals/2016-2017/extracellular-vesicles-released-glioblastoma-cells-saboteurs-biomarkers

NLM Title:	Extracellular vesicles released by glioblastoma cells : saboteurs, biomarkers and therapeutics / Xandra O. Breakefield.
Author:	Breakefield, Xandra O. National Institutes of Health (U.S.),
Publisher:
Abstract:	(CIT): NIH Director's Wednesday Afternoon Lecture Series Xandra Breakefield, Ph.D. is a basic scientist with a strong background in molecular genetics and neuroscience. She focuses her research efforts on: gene therapy for neurologic diseases; and elucidation of the role of extracellular vesicles (EVs) released from cancer cells in tumor progression. She led early studies demonstrating mutant RNA in serum EVs from glioblastoma patients as biomarkers. Professor Breakefield has received a number of awards for her work, including a McKnight Foundation Neuroscience Development Award, two Javits Neuroscience Investigator Awards, the Society for Neuroscience Mika Salpeter Lifetime Achievement Award, and the Harvard Medical School William Silen Lifetime Achievement Mentoring Award. She is a member of the National Academy of Arts and Sciences and past president of the American Society of Gene and Cell Therapy.
Subjects:	Extracellular Vesicles Glioblastoma
Publication Types:	Lecture Webcast

NLM Classification:	QZ 380
NLM ID:	101706990
CIT Live ID:	23350
Permanent link:	https://videocast.nih.gov/watch=23350

Related Videos...